Chronic kidney disease alters intestinal microbial flora

Slides:



Advertisements
Similar presentations
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Advertisements

Volume 133, Issue 1, Pages (July 2007)
Figure 1. The relationships of bacterial operational taxonomic unit richness (A) and phylogenetic diversity (B) with aridity index based on 97% sequence.
MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz 
Chronic kidney disease alters intestinal microbial flora
Volume 141, Issue 5, Pages (November 2011)
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 83, Issue 3, Pages (March 2013)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Shining light on vitamin D trials in chronic kidney disease
Volume 86, Issue 6, Pages (December 2014)
Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma  F. Avilés-Jiménez, A. Guitron,
Volume 61, Issue 2, Pages (February 2002)
Volume 139, Issue 6, Pages e1 (December 2010)
Prehypertension and chronic kidney disease: the ox or the plow?
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
Volume 11, Issue 4, Pages (April 2015)
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 133, Issue 1, Pages (July 2007)
Alterations in the Gut Microbiota Associated with HIV-1 Infection
Conducting a Microbiome Study
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 70, Pages S21-S25 (December 2006)
Volume 10, Issue 11, Pages (March 2015)
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Taxonomic composition of the baboon and human gut microbiota.
Comorbidity and confounding in end-stage renal disease
Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing?  Gautam R. Shroff, Charles A. Herzog 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
FIGURE 1 α-Diversity comparisons of gut microbiota from DM and MOM infants by age and antibiotic exposure. Using ... FIGURE 1 α-Diversity comparisons of.
Use of vitamin D in chronic kidney disease patients
Volume 87, Issue 4, Pages (April 2015)
Volume 86, Issue 1, Pages (July 2014)
Volume 70, Issue 12, Pages (December 2006)
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Volume 75, Issue 1, Pages (January 2009)
Altered tryptophan metabolism and CKD-associated fatigue
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 6, Pages (September 2009)
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 3, Pages (February 2006)
Elevated risk of stroke among patients with end-stage renal disease
Alternate-day dialysis may be needed for hemodialysis patients
Methods for guideline development
Volume 76, Issue 8, Pages (October 2009)
Atrial fibrillation in end-stage renal disease: an emerging problem
The global challenge of chronic kidney disease
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Unilateral renal cystic disease
Volume 63, Issue 1, Pages (January 2003)
Prehypertension: is it relevant for nephrologists?
Cardio-Kidney-Damage: a unifying concept
The Case ∣ Hypocalcemia, chronic renal failure and dysmorphism?
Volume 76, Issue 6, Pages (September 2009)
Volume 80, Issue 10, Pages (November 2011)
Volume 75, Issue 7, Pages (April 2009)
Changes to the End-Stage Renal Disease Quality Incentive Program
Volume 88, Issue 5, Pages (November 2015)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
O.M. Gutiérrez, T. Isakova, D.L. Andress, A. Levin, M. Wolf 
Gene Profiling of Keloid Fibroblasts Shows Altered Expression in Multiple Fibrosis- Associated Pathways  Joan C. Smith, Braden E. Boone, Susan R. Opalenik,
Sugar-sweetened beverages and chronic disease
Similarity of non-neoplastic and neoplastic colonic disease associated bacterial profiles. Similarity of non-neoplastic and neoplastic colonic disease.
Presentation transcript:

Chronic kidney disease alters intestinal microbial flora Nosratola D. Vaziri, Jakk Wong, Madeleine Pahl, Yvette M. Piceno, Jun Yuan, Todd Z. DeSantis, Zhenmin Ni, Tien-Hung Nguyen, Gary L. Andersen  Kidney International  Volume 83, Issue 2, Pages 308-315 (February 2013) DOI: 10.1038/ki.2012.345 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Relative richness of the gut microbiome in the study groups. Relative richness comprised of the average number of (a) subfamilies per subphylum for control (CTL) or end-stage renal disease (ESRD) patients or (b) species per class for control (CTL) and chronic renal failure (CRF) rats. A subfamily or species had to be present in at least three replicates of a treatment group and also had to have an average of four subfamilies or species present in a subphylum or class to be included in the figure. Kidney International 2013 83, 308-315DOI: (10.1038/ki.2012.345) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Two-dimensional representation (plane of view) of non-metric multidimensional scaling analysis of standardized operational taxonomic unit (OTU) intensities (hybridized probe sets) for the dynamic subset of the microbial community consisting of 190 PhyloChip OTUs from controls or end-stage renal disease (ESRD) patients. Stress=0.10. Each point is a human fecal community from control (C) or ESRD individuals. The model is based on a Bray–Curtis similarity matrix. Connecting lines were used to aid in the visualization of the distribution of all members of a group. Kidney International 2013 83, 308-315DOI: (10.1038/ki.2012.345) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Two-dimensional representation of non-metric multidimensional scaling analysis of standardized operational taxonomic unit (OTU) intensities (hybridized probe-sets) in bacterial communities of rat fecal microbiota. Stress=0.02. The model is based on a Bray–Curtis similarity matrix. Connecting lines were used to aid in the visualization of the distribution of all members of a group. CKD, chronic kidney disease; CRF, chronic renal failure; CTL, control. Kidney International 2013 83, 308-315DOI: (10.1038/ki.2012.345) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Hierarchical clustering of probe sets representing significantly different operational taxonomic units (OTUs) between groups with a minimum two-fold change in untransformed intensities between samples to show relative abundance. Yellow indicates increased abundance and red indicates decreased abundance relative to the mean for each OTU. Columns represent rat fecal microbiota composition for control (CTL) and chronic renal failure (CRF) individual rats. Rows are OTUs with mean fold change among samples and cluster based on the similarity of their abundance profiles across the data set, with similar OTUs connected at the hierarchical tree on the left. Bars on the right represent (1) OTUs from the Firmicutes (especially Lactobacillaceae and a few Coprococcus within the Lachnospiraceae), Bacteroidetes (Prevotellaceae, two Rikenellaceae OTUs) that had higher abundances in CTL samples, or (2) OTUs from the Firmicutes (unclassified Lachnospiraceae) and other Rikenellaceae (in Bacteroides) that have higher abundances in CRF samples. Kidney International 2013 83, 308-315DOI: (10.1038/ki.2012.345) Copyright © 2013 International Society of Nephrology Terms and Conditions